In a subgroup analysis for only HPV45 case-control pairs, the effect did not reach statistical significance for HPV45 Cases and Controls (RC + HRC), where controls were 52% more likely than cases to have a one-log unit increase in anti-HPV18 antibody titers (OR = 1.52, 95% CI: 0.98–2.38; p = 0.1362).
← all excerpts
Evaluation of Anti-HPV18 Antibody Titers Preceding an Incident Cervical HPV18/45 Infection.
1
—
—